On Friday, Quest Diagnostics Inc (DGX) stock saw a modest uptick, ending the day at $160.44 which represents a slight increase of $3.60 or 2.30% from the prior close of $156.84. The stock opened at ...
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Quest Diagnostics Inc.’s DGX robust Advanced Diagnostics offering is poised to drive its growth in the upcoming quarters. Strength in the company’s core business is highly encouraging. Additionally, a ...